Philip Caenepeel

Appearances

TREATMENT WITH THE HISTAMINE 1 RECEPTOR ANTAGONIST EBASTINE FOR NON-CONSTIPATED IRRITABLE BOWEL SYNDROME: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL
Date
May 18, 2024
Our previous pilot study showed that treatment with the histamine 1 receptor antagonist ebastine improved symptoms in patients with irritable bowel syndrome (IBS)…
Presenter
Lisse Decraecker
Speakers
Fedrica Pia
Danny De Looze
David Hirsch
Heiko De Schepper
Joris Arts
Philip Caenepeel
Arjan Bredenoord
Amsterdam UMC, University of Amsterdam
Tim Vanuytsel
Ann Belmans
Guy Boeckxstaens